American Diabetes Association--69th Scientific sessions. Obesity management and treatment of type 2 diabetes: Part 1.
Kouremenou
Chrissie
C
Thomson Reuters, London, UK. chrisoula.kouremenou@thomsonreuters.com
D000818:Animals; D019440:Anti-Obesity Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004353:Drug Evaluation, Preclinical; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D009765:Obesity / Q000188:drug therapy*
D019440:Anti-Obesity Agents; D015507:Drugs, Investigational; D007004:Hypoglycemic Agents